Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Cabo Medicine ApS
APS
Active
CVR 44825775
Svendborgvej 226
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2024
3 employees
cabomedicine.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 937K
EBITDA margin
5.9%
Equity ratio
25.3%
Financial strength
Net profit 2025
DKK 7K
3 employees
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Key figures
Annual report 2025
Revenue
DKK 937K
—
EBITDA
DKK 55K
—
Net profit
DKK 7K
—
Total assets
DKK 264K
—
Equity
DKK 67K
—
Employees
3
—
Company information
Legal name
Cabo Medicine ApS
CVR number
44825775
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. maj 2024
Share capital
DKK 60.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed med konsulentydelser inden for medicinalindustrien og anden hermed beslægtet virksomhed.
Contact
Address
Svendborgvej 226
Phone
+4566443535
Email
info@cabomedicine.com
Website
cabomedicine.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
DKK thousands
Item
2025
Revenue
937
Staff expenses
-882
EBITDA
55
Depreciation & amort.
-0
EBIT
55
Net financials
-32
Profit before tax
23
Tax
17
Net profit
7
Balance sheet
DKK thousands
Item
2025
Total assets
264
Equity
67
Long-term debt
0
Short-term debt
197
Total debt
197
Financial ratios
5-year trend
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
2025
2025
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
2025
2025
Return on equity
10.0%
This company
18.4%
Market median
-46% vs market
2025
2025
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
2025
2025
Asset turnover
3.55×
This company
1.12×
Market median
+217% vs market
2025
2025
Debt / equity
2.95×
This company
0.62×
Market median
-376% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-13 – 2025-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
RT
Rasmus Thinggaard Callesen
Management
Management
2024
JR
Jesper Rolskov Bojsen
Management
Management
2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Rasmus Callesen Holding ApS
Company
50–66.65%
50–66.65%
2024
Jesper Bojsen Holding ApS
Company
50–66.65%
50–66.65%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Rasmus Callesen Holding ApS
Cabo Medicine ApS
(this company)
Board network connections
Board members of Cabo Medicine ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Rasmus Thinggaard Callesen
Management
0 companies
Jesper Rolskov Bojsen
Management
0 companies